[Clinical guidelines for diagnosing, treatment and monitoring patients with bladder cancer--Croatian Oncology Society and Croatian Urology Society, Croatian Medical Association].
Urothelial cancer is the most common bladder cancer. Hematuria is the most common presenting symptom in patients with bladder cancer. The most common diagnostics of bladder cancer is performed by transurethral resection of bladder after which pathohistological diagnosis is set. It is necessary to determine whether the cancer penetrated in muscle layer (muscle-invasive cancer) or not (muscle-noninvasive cancer). Decision on therapeutic modality depends on the clinical stage of disease and on prognostic and risk factors. For muscle non-invasive bladder cancer transurethral resection is preferred with or without intravesical instillation of Bacillus Calmette-Guérin (BCG). For invasive cancer the method of choice is radical cystectomy. Radiotherapy is used in radical and palliative purposes. Metastatic disease is most frequently treated by chemotherapy metotrexate/vinblastine/doxorubicine/cisplatin (MVAC) or gemcitabine/cisplatin (GC). The purpose of this article is to present clinical recommendations to set standards of procedures and criteria in diagnostics, treatment and follow up of patients with bladder cancer in the Republic of Croatia.
Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb, Zagreb.
Marija
M
Gamulin
Medicinski fakultet Sveucilista u Rijeci, KBC Rijeka, Rijeka.
Ira Pavlović
IP
Ruzić
Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb, Zagreb.
Mislav
M
Grgić
KBC Sestre milosrdnice, Zagreb.
Marijana
M
Jazvić
Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb, Zagreb.
Mladen
M
Solarić
Medicinski fakultet Sveucilista u Rijeci, KBC Rijeka, Rijeka.
Dag
D
Zahirović
KBC Sestre milosrdnice, Zagreb.
Robert
R
Zorica
Medicinski fakultet Sveucilista u Splitu, KBC Split, Split.
Tomislav
T
Omrcen
Medicinski fakultet Sveucilista u Rijeci, KBC Rijeka, Rijeka.
Marija
M
Petković
Medicinski fakultet Sveucilista u Osijeku, KBC Osijek, Osijek.
Mate
M
Matić
Medicinski fakultet Sveucilista u Rijeci, KBC Rijeka, Rijeka.
Zeljko
Z
Fuckar
KBC Sestre milosrdnice, Zagreb.
Boris
B
Ruzić
Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb, Zagreb.
Josip
J
Pasini
Medicinski fakultet Sveucilista u Splitu, KBC Split, Split.
Marijan
M
Situm
Medicinski fakultet Sveucilista u Rijeci, KBC Rijeka, Rijeka.
Gordana
G
Dordević
Medicinski fakultet Sveucilista u Rijeci, KBC Rijeka, Rijeka.
Damir
D
Miletić
Medicinski fakultet Sveucilista u Splitu, KBC Split, Split.
Tade
T
Tadić
Medicinski fakultet Sveucilista u Zagrebu, KBC Zagreb, Zagreb.
Zeljko
Z
Kastelan
Medicinski fakultet Sveucilista u Splitu, KBC Split, Split.
Davor
D
Librenjak
Klinicka bolnica Sveti Duh, Zagreb.
Ivan
I
Gilja
Medicinski fakultet Sveucilista u Splitu, KBC Split, Split.
Katarina
K
Vilović
KBC Sestre milosrdnice, Zagreb.
Bozo
B
Kruslin
Medicinski fakultet Sveucilista u Osijeku, KBC Osijek, Osijek.
Hrvoje
H
Kuvezdić
D017523:Croatia; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis* / Q000628:therapy*